OpenAI Launches GPT-Rosalind AI Model for Life Sciences Research
OpenAI has officially launched GPT-Rosalind, a specialized artificial intelligence model designed to accelerate research in life sciences, including biochemistry, drug discovery, and translational medicine. Named after the renowned British scientist Rosalind Franklin, the model aims to support researchers by synthesizing evidence, generating hypotheses, planning experiments, and querying scientific databases. It is built upon OpenAI’s latest internal models and is available as a research preview through ChatGPT, Codex, and the API for qualified customers under a trusted access deployment structure. To further assist scientists, OpenAI is introducing a free Life Sciences research plugin for Codex, which connects users to over 50 scientific tools and data sources. The company is already collaborating with major industry players such as Amgen, Moderna, and Thermo Fisher Scientific to integrate GPT-Rosalind into their workflows. This launch reflects the growing demand for AI-powered tools in pharmaceutical and biotech sectors, aiming to streamline the early stages of scientific discovery. The announcement coincides with OpenAI's broader expansion into specialized AI applications, following the recent unveiling of a cybersecurity-focused model variant.
Wire timeline
OpenAI Launches GPT-Rosalind AI Model for Life Sciences Research
OpenAI has officially launched GPT-Rosalind, a specialized artificial intelligence model designed to accelerate research in life sciences, including biochemistry, drug discovery, and translational medicine. Named after the renowned British scientist Rosalind Franklin, the model aims to support researchers by synthesizing evidence, generating hypotheses, planning experiments, and querying scientific databases. It is built upon OpenAI’s latest internal models and is available as a research preview through ChatGPT, Codex, and the API for qualified customers under a trusted access deployment structure. To further assist scientists, OpenAI is introducing a free Life Sciences research plugin for Codex, which connects users to over 50 scientific tools and data sources. The company is already collaborating with major industry players such as Amgen, Moderna, and Thermo Fisher Scientific to integrate GPT-Rosalind into their workflows. This launch reflects the growing demand for AI-powered tools in pharmaceutical and biotech sectors, aiming to streamline the early stages of scientific discovery. The announcement coincides with OpenAI's broader expansion into specialized AI applications, following the recent unveiling of a cybersecurity-focused model variant.
The Indian Express